ELI KENNERLY MARSHALL JR. PROFESSORSHIP IN ONCOLOGY
Established in 1978 by the University in honor of Eli Kennerly Marshall Jr.

ELI KENNERLY MARSHALL JR., A&S 1911 (PhD), Med 1917, was head of the Department of Pharmacology and Experimental Therapeutics for more than two decades and was considered one of the most renowned pharmacologists of his time. After earning his doctorate in chemistry, he joined the medical faculty while earning his MD. Dr. Marshall was appointed to head his department when the eminent John J. Abel, after 30 years in the position, announced his wish to retire. Dr. Marshall established the first clinical pharmacology unit in the nation, was among the first to study the new sulfonamide drugs and developed two new such drugs, contributed to the development of antimalarial drugs, and devised a method for measuring cardiac output. The most outstanding discovery of his career was the demonstration of secretion by the renal tubules. He retired in 1955 and died in 1966.

 

GARY L. ROSNER, the Eli Kennerly Marshall Jr. Professor of Oncology, is internationally recognized as a distinguished scholar in the field of biostatistics and was successfully recruited to the Johns Hopkins faculty in 2010 as a professor of oncology and director of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins' Quantitative Sciences Program and the Division of Biostatistics and Bioinformatics. At the Kimmel Cancer Center, Dr. Rosner leads a dedicated and expert team of faculty and staff. The Division of Biostatistics and Bioinformatics is a core element for progress in each of the Cancer Center's research programs.

Before joining Johns Hopkins, Dr. Rosner held faculty appointments at the University of Texas M.D. Anderson Cancer Center, as well as in the Graduate School of Biomedical Sciences at the University of Texas Health Science Center-Houston, where he was the inaugural program director for the Program in Biomathematics and Biostatistics. Prior to that, he was a member of the faculties of the Duke University Medical Center and the Department of Epidemiology and Public Health at the Yale University School of Medicine.

Dr. Rosner received his BA from the State University of New York, Buffalo, and his MA MSc from Rice University in Houston. He earned his doctoral degree from Harvard University. His postgraduate training was in applied mathematical sciences at Rice University and in biostatistics at Harvard.

Dr. Rosner carries out resesearch into statistical methods to improve the design and analysis of studies that take account of the complex nature of cancer research. A particular focus of his research is the application of Bayesian inferential methods in biostatistics, particular in studies of a drug therapy's pharmokinetics and pharmacodynamics.